Page last updated: 2024-10-27

fluconazole and Extramembranous Glomerulopathy

fluconazole has been researched along with Extramembranous Glomerulopathy in 2 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"Fluconazole is a synthetic antifungal triazole that is often used."2.82Immune-mediated membranous nephropathy: Long term fluconazole usage caused podocyte autophagy. ( Dong, QR; Hu, GC; Huang, L; Zhao, YJ, 2022)
"Fluconazole is a widely used antifungal agent that was never implicated in the development of membranous nephropathy."1.34Membranous nephropathy associated with fluconazole treatment. ( Kim, H; Park, J; Shin, GT; Yim, H, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Huang, L1
Zhao, YJ1
Dong, QR1
Hu, GC1
Shin, GT1
Yim, H1
Park, J1
Kim, H1

Reviews

1 review available for fluconazole and Extramembranous Glomerulopathy

ArticleYear
Immune-mediated membranous nephropathy: Long term fluconazole usage caused podocyte autophagy.
    Journal of biochemical and molecular toxicology, 2022, Volume: 36, Issue:1

    Topics: Autophagy; Fluconazole; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Podocytes

2022

Other Studies

1 other study available for fluconazole and Extramembranous Glomerulopathy

ArticleYear
Membranous nephropathy associated with fluconazole treatment.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2007, Volume: 49, Issue:2

    Topics: Female; Fluconazole; Glomerulonephritis, Membranous; Humans; Middle Aged

2007